299 related articles for article (PubMed ID: 15838352)
1. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage.
Yen CP; Chen SC; Lin TK; Wu SC; Chang CY; Lue SI; Jeng AY; Kassell NF; Kwan AL
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S474-8. PubMed ID: 15838352
[TBL] [Abstract][Full Text] [Related]
2. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage.
Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS
Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.
Lin CL; Kwan AL; Dumont AS; Su YF; Kassell NF; Wang CJ; Wu SC; Kuo CL; Huang CS; Jeng AY; Liu CS
J Neurosurg; 2007 Mar; 106(3):442-8. PubMed ID: 17367067
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.
Lin CL; Shih HC; Lieu AS; Lee KS; Dumont AS; Kassell NF; Howng SL; Kwan AL
J Neurosurg; 2007 Mar; 106(3):436-41. PubMed ID: 17367066
[TBL] [Abstract][Full Text] [Related]
6. Effect of smoking on rat basilar artery: correlation with inducible nitric oxide synthase and endothelin converting enzyme-1.
Koc K; Anik I; Bozkurt SU; Ercin C; Ceylan S
Turk Neurosurg; 2009 Oct; 19(4):393-9. PubMed ID: 19847761
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat.
Dai ZK; Hsieh CC; Chai CY; Wu JR; Jeng AY; Chou SH; Wu BN; Yeh JL; Chen IJ; Tan MS
Pediatr Pulmonol; 2010 Nov; 45(11):1076-85. PubMed ID: 20658482
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
Chang CZ; Yen CP; Winadi D; Wu SC; Howng SL; Lin TK; Jeng AY; Kassell NF; Kwan AL
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S487-9. PubMed ID: 15838355
[TBL] [Abstract][Full Text] [Related]
9. The role of constitutive and inducible nitric oxide synthase in the human brain after subarachnoid hemorrhage.
Berra LV; Carcereri De Prati A; Suzuki H; Pasqualin A
J Neurosurg Sci; 2007 Mar; 51(1):1-9. PubMed ID: 17369785
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor.
Kwan AL; Lin CL; Chang CZ; Wu SC; Howng SL; Jeng AY
Neuroreport; 2002 Feb; 13(2):197-9. PubMed ID: 11893909
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor.
Kwan AL; Bavbek M; Jeng AY; Toyoda T; Kassell NF; Lee KS
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S320-2. PubMed ID: 9595470
[TBL] [Abstract][Full Text] [Related]
12. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of hemolysate-induced cerebrovascular endothelial cell injury and of production of endothelin-1 and big endothelin-1 by an endothelin-converting enzyme inhibitor.
Chang CZ; Winardi D; Lin CL; Kwan AL; Jeng AY; Kassell NF; Howng SL; Lee KS
Surg Neurol; 2002; 58(3-4):181-7; discussion 187-8. PubMed ID: 12480208
[TBL] [Abstract][Full Text] [Related]
14. Functional neuroprotective effect of CGS 26303, a dual ECE inhibitor, on ischemic-reperfusion spinal cord injury in rats.
Chou AK; Chen TI; Winardi W; Dai MH; Chen SC; Howng SL; Yen CP; Lin TK; Jeng AY; Kwan AL
Exp Biol Med (Maywood); 2007 Feb; 232(2):214-8. PubMed ID: 17259328
[TBL] [Abstract][Full Text] [Related]
15. Section on cerebrovascular surgery: Galbraith Award: Endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1) gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage (SAH) and post-SAH cerebral vasospasm.
Khurana VG; Sohni YR; Mangrum WI; McClelland RL; O'Kane DJ; Meyer FB; Meissner I
Clin Neurosurg; 2004; 51():343-50. PubMed ID: 15571165
[No Abstract] [Full Text] [Related]
16. Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys.
Ono S; Zhang ZD; Marton LS; Yamini B; Windmeyer E; Johns L; Kowalczuk A; Lin G; Macdonald RL
J Cereb Blood Flow Metab; 2000 Jul; 20(7):1066-76. PubMed ID: 10908040
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm.
Shimada Y; Tsunoda H; Zang L; Hirano M; Oka T; Tanaka T
Eur J Pharmacol; 2009 Oct; 620(1-3):16-20. PubMed ID: 19686725
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
[TBL] [Abstract][Full Text] [Related]
19. Alteration of basilar artery rho-kinase and soluble guanylyl cyclase protein expression in a rat model of cerebral vasospasm following subarachnoid hemorrhage.
Wang CJ; Lee PY; Wu BN; Wu SC; Loh JK; Tsai HP; Chung CL; Kassell NF; Kwan AL
Biomed Res Int; 2014; 2014():531508. PubMed ID: 24982890
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitor.
Shetty SS; Savage P; DelGrande D; De Lombaert S; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S68-70. PubMed ID: 9595403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
